PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings. The information provided on PharmiWeb.com is ...

Luforbec 100µg/6µg pMDI is indicated for adult asthma and COPD treatment, where the use of an inhaled corticosteroid and long-acting beta2-agonist (ICS/LABA) is suitable. With the same active ...

Luforbec ® 100/6 (beclometasone 100mcg / formoterol 6mcg) pMDI, first branded generic alternative to Fostair ® 100/6 pMDI to treat Asthma & COPD, is now available in the UK Lupin continues their ...

People using beclometasone inhalers for asthma or other health conditions may want to read up on the NHS guidance for the medication. These steroid inhalers are often prescribed as a 'preventer' ...

Hormosan Pharma GmbH, a wholly-owned subsidiary of the company in Germany, has introduced Luforbec in the European nation, Lupin said in a statement. Find the best of Al News in one place, specially ...

People prescribed beclometasone inhalers are encouraged to read up on the NHS guidelines for the drug. The inhalers are often prescribed for people with asthma, and sometimes for other respiratory ...

People who rely on beclometasone inhalers for asthma or other respiratory issues may want to read up on the official NHS recommendations for this treatment. These steroid inhalers are typically issued ...

People who rely on beclometasone inhalers for asthma or other respiratory issues may want to read up on the official NHS recommendations for this treatment. These steroid inhalers are typically issued ...

Respiratory diseases affect one in five people. It is the third biggest cause of death in the UK and is a clinical priority for the NHS. Lupin's UK subsidiary, Lupin Healthcare (UK), has received the ...

Hormosan Pharma GmbH (Hormosan), Lupin’s wholly-owned subsidiary in Germany, announced the launch of Luforbec 100/6 (beclometasone 100 µg / formoterol 6 µg), a fix combination in a pressurized metered ...

Lupin news: Drug firm Lupin on Friday said its unit has launched a pressurized metered dose inhaler for the treatment of asthma and chronic obstructive pulmonary disease (COPD) in Germany. Lupin news: ...